CALA (Calithera Biosciences) Current Accrued Expense: $4.94 Mil (As of Dec. 2022)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Calithera Biosciences Current Accrued Expense?

Calithera Biosciences CALA Current Accrued Expense is $4.94 Mil as of Dec. 2022.

Calithera Biosciences's Current Accrued Expense for the quarter that ended in Dec. 2022 was $4.94 Mil.

Calithera Biosciences's quarterly Current Accrued Expense declined from Jun. 2022 ($6.35 Mil) to Sep. 2022 ($6.15 Mil) and declined from Sep. 2022 ($6.15 Mil) to Dec. 2022 ($4.94 Mil).

Calithera Biosciences's annual Current Accrued Expense declined from Dec. 2020 ($13.05 Mil) to Dec. 2021 ($8.94 Mil) and declined from Dec. 2021 ($8.94 Mil) to Dec. 2022 ($4.94 Mil).

Calithera Biosciences Current Accrued Expense Related Terms

Calithera Biosciences Current Accrued Expense Historical Data

* Premium members only.

The historical data trend for Calithera Biosciences's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Calithera Biosciences Current Accrued Expense Chart

Calithera Biosciences Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Current Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.17 13.32 13.05 8.94 4.94

Calithera Biosciences Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.94 7.33 6.35 6.15 4.94

Calithera Biosciences Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

What does a Current Accrued Expense of $4.94 Mil mean?
Calithera Biosciences (CALA) has a Current Accrued Expense of $4.94 Mil as of Dec. 2022. Current Accrued Expense records the total amount of accrued expenses. View historical data on Calithera Biosciences and its competitors.
Is Calithera Biosciences' Current Accrued Expense too high?
Calithera Biosciences' current Current Accrued Expense is $4.94 Mil.
How does Calithera Biosciences' Current Accrued Expense compare to PPCB and QBIO?
Calithera Biosciences' Current Accrued Expense of $4.94 Mil can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Accrued Expense for a Diversified Financial Services company?
A good Current Accrued Expense depends on the Diversified Financial Services industry context. However, Current Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Accrued Expense mean?
A high Current Accrued Expense can signal that a stock is expensive relative to its fundamentals. Current Accrued Expense records the total amount of accrued expenses. View historical data on Calithera Biosciences and its competitors. Calithera Biosciences's current Current Accrued Expense is $4.94 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Calithera Biosciences stock overvalued right now?
Calithera Biosciences (CALA) has a current Current Accrued Expense of $4.94 Mil. The current Current Accrued Expense is $4.94 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Accrued Expense calculated?
Current Accrued Expense is calculated from a company's financial statements. For Calithera Biosciences (CALA), the current Current Accrued Expense is $4.94 Mil as of Dec. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Calithera Biosciences Business Description

Address 343 Oyster Point Boulevard, Suite 200, South San Francisco, CA, USA, 94080
Calithera Biosciences Inc is a shell company.